Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Frontiers in Pharmacology|February 15, 2021
Case Report: Fatal Multiorgan Failure and Heterochronous Pneumonitis Following Pembrolizumab Treatment in a Patient With Large-Cell Neuroendocrine Carcinoma of LungXiaohong Xie, Fei Wang, Yinyin Qin, et al.
Translational Lung Cancer Research|July 17, 2025
Assessing the clinical impact of severe lung cancer on non-small cell lung cancer: a single-center retrospective studyHuixin Jiang, Ling Yi, Du Feng, et al.
Translational Cancer Research|February 4, 2022
The clinical analysis of pulmonary lymphoepithelioma-like carcinoma with epithelioid granulomaGuoying Gao, Chengzhi Zhou, Guofeng Wu, et al.
American Journal of Cancer Research|October 11, 2023
Combined small cell lung cancer: current progress and unmet needsChen Zeng, Guihuan Qiu, Xiaohong Xie, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 12, 2023
Characteristics and prognosis of EGFR mutations in small cell lung cancer patients in the NGS eraXiaohong Xie, Guihuan Qiu, Ziyao Chen, et al.
Signal Transduction and Targeted Therapy|February 17, 2025
Induction chemotherapy followed by camrelizumab plus apatinib and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: a multicenter, single-arm trialMing Liu, Guihuan Qiu, Wenhui Guan, et al.
Cancer Medicine|July 18, 2023
A retrospective real-world experience of immunotherapy in patients with extensive stage small-cell lung cancerGuihuan Qiu, Fei Wang, Xiaohong Xie, et al.
Translational Lung Cancer Research|December 15, 2022
Treatment response and safety of immunotherapy for advanced non-small cell lung cancer with comorbid chronic obstructive pulmonary disease: a retrospective cohort studyKening Zhang, Chengzhi Zhou, Jiabo Gao, et al.
Human Vaccines & Immunotherapeutics|August 4, 2025
Real-world single-center data analysis of dual immunotherapy in advanced NSCLC: Efficacy, survival, and adverse eventsTao Luan, Jianqing Hao, Xiaohong Xie, et al.
Frontiers in Oncology|June 13, 2022
The Treatment Status of Patients in NSCLC With RET Fusion Under the Prelude of Selective RET-TKI Application in China: A Multicenter Retrospective ResearchYan Meng, Yilin Yang, Yujia Fang, et al.
Pageof 9